TYRX Gains FDA Clearance For Resorbable Antibacterial Device Envelope

TYRX Inc. has received FDA clearance for a fully-resorbable version of its antibacterial envelope, used to prevent surgical site infections in patients who receive implantable devices such as ICDs. The resorbable device has important advantages over the previous durable envelope and could substantially boost physician adoption of the company’s technology.

Read More:
TYRX Gains FDA Clearance For Resorbable Antibacterial Device Envelope

Tags: , , , , , , , , ,

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Contact Us

Click or drag a file to this area to upload.